PharmTech Europe News

PRAC Recommends New Measures to Avoid Topiramate Exposure in Pregnancy

September 11, 2023

Topiramate can cause serious birth defects if exposed to children in the womb.

Harnessing the Power of Oncolytic Viruses

September 03, 2023

Tumour-infiltrating lymphocyte (TIL) therapies offer a new route to target cancer.

Booster Shot for Pharma

September 02, 2023

European vaccine manufacturing is being boosted with high level investments.

Pfizer and BioNTech Get Positive Opinion in Europe for Omicron XBB.1.5-adapted COVID-19 Vaccine

August 31, 2023

The updated vaccine will be ready to ship following a positive European Commission review.

Sirio Europe Announces New Softgel Formulations

August 30, 2023

The new products aim to aid consumers with menopause and eye health-related issues.

Three-Way Collaboration Between Rentschler Biopharma, CGT Catapult, and Refeyn Aims to Improve PAT for Gene Therapy Manufacturing

August 29, 2023

Rentschler Biopharma, CGT Catapult, and Refeyn aim to use automated and digital technologies to improve AAV manufacturing for gene therapies.

Alterity Therapeutics Given European Composition of Matter Patent for Neurodegenerative Diseases

August 24, 2023

The patent grants Alterity 20 years of exclusivity over a new class of iron chaperone drug candidates.

EMA Reviews Data on Paternal Exposure to Valproate

August 18, 2023

The assessment aims to determine whether valproate use in men could lead to neurodevelopmental disorders in their children.

Amicus Therapeutics Launches Pompe Disease Therapy in United Kingdom

August 17, 2023

The indication for Pombiliti is a long-term enzyme replacement therapy (ERT) used in combination with miglustat for adults with late-onset Pompe disease (LOPD).

United Kingdom Biotech Report Finds 29% Uptick in Funding

August 14, 2023

A report from the UK Bioindustry Association report indicated that biotech venture and public financing rose from £295 million in the first quarter to £382 million in the second quarter.